Home Mallinckrodt buying Cadence Pharmaceuticals for approximately $1.21 billion
 

Keywords :   


Mallinckrodt buying Cadence Pharmaceuticals for approximately $1.21 billion

2014-02-11 17:48:35| Biotech - Topix.net

The health care products company Mallinckrodt is buying Cadence Pharmaceuticals for about $1.21 billion in a bid to strengthen its specialty drugs unit.

Tags: approximately buying billion pharmaceuticals

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
21.05Eastern North Pacific Tropical Weather Outlook
21.05UK has room for three rate cuts this year, IMF says
21.05NOS Portugal adds 250 pay TV subscribers in 1Q 2024
21.05Farm Progress America, May 21, 2024
21.05ATEME integrates Advanced HDR by Technicolor
21.0520% of US internet households subscribe to a gaming service
21.05StarHub Entertainment subscribers down 8,000 in 1Q2024
21.05Groupe M6 launches M6+ free streaming platform
More »